Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option

被引：0
|
作者：
D Călugăru
M Călugăru
机构：
[1] University of Medicine Grigore T Popa,Department of Ophthalmology
[2] University of Medicine,Department of Ophthalmology
来源：
Eye | 2017年 / 31卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：342 / 342
相关论文
共 50 条
  • [31] Aflibercept monotherapy or bevacizumab first for diabetic macular edema
    Hostovsky, Avner
    Moroz, Iris
    Katz, Gabriel
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2024, 72 (SUPPL 2) : S260 - S264
  • [32] Effect of intravitreal aflibercept on recalcitrant diabetic macular edema
    Klein K.A.
    Cleary T.S.
    Reichel E.
    International Journal of Retina and Vitreous, 3 (1)
  • [33] Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema
    Jhaveri, Chirag D.
    Glassman, Adam R.
    Ferris, Frederick L., III
    Liu, Danni
    Maguire, Maureen G.
    Allen, John B.
    Baker, Carl W.
    Browning, David
    Cunningham, Matthew A.
    Friedman, Scott M.
    Jampol, Lee M.
    Marcus, Dennis M.
    Martin, Daniel F.
    Preston, Carin M.
    Stockdale, Cynthia R.
    Sun, Jennifer K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (08): : 692 - 703
  • [34] Evaluating the Treatment of Diabetic Macular Edema with Aflibercept Based on a Regional Network of Ophthalmologic Care Givers
    Khalil, Haidar
    Mariacher, Siegfried
    Strauss, Rupert
    Podkowinski, Dominika
    Waser, Klemens
    Bolz, Matthias
    JOURNAL OF OPHTHALMOLOGY, 2023, 2023
  • [35] Retrospective analysis of the efficacy of early switching from bevacizumab to aflibercept or ranibizumab in diabetic macular edema
    Atas, Mustafa
    Ozsaygili, Cemal
    Bayram, Nurettin
    Unal, Sefa
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2023, 33 (02) : 1132 - 1139
  • [36] Efficacy and safety of aflibercept therapy for diabetic macular edema: A systematic review and meta-analysis
    Santhakumaran, Sangeetha
    Salimi, Ali
    Brunetti, Vanessa C.
    Galic, John
    JOURNAL OF CURRENT OPHTHALMOLOGY, 2022, 34 (02): : 133 - +
  • [37] EFFICACY AND SAFETY OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOCUSING ON PATIENTS WITH DIABETIC MACULAR EDEMA FROM JAPAN
    Terasaki, Hiroko
    Shiraki, Kunihiko
    Ohji, Masahito
    Metzig, Carola
    Schmelter, Thomas
    Zeitz, Oliver
    Sowade, Olaf
    Kobayashi, Masato
    Vitti, Robert
    Berliner, Alyson
    Shiraga, Fumio
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (05): : 938 - 947
  • [38] EFFICACY OF INTRAVITREAL DEXAMETHASONE IMPLANT TREATMENT IN DIABETIC MACULAR EDEMA REFRACTORY TO INTRAVITREAL AFLIBERCEPT TREATMENT
    Celik, E.
    Sever, O.
    Cakir, B.
    Dogan, E.
    Ozmen, S.
    Atum, M.
    Aksoy, N.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (03) : NP29 - NP29
  • [39] Macular Ischemia Changes in Patients with Diabetic Macular Edema Treated with Aflibercept and Ranibizumab
    Maris, Dimitrios
    Dastiridou, Anna
    Kotoula, Maria
    Karathanou, Aikaterini
    Tsironi, Evangelia E.
    Bargiota, Alexandra
    Androudi, Sofia
    DIAGNOSTICS, 2024, 14 (12)
  • [40] Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
    Wang, Jia-Kang
    Su, Pei-Yuan
    Hsu, Yung-Ray
    Chen, Yun-Ju
    Chen, Fang-Ting
    Tseng, Ying-Yu
    JOURNAL OF OPHTHALMOLOGY, 2016, 2016
12345